SWIRE PROPERTIES (01972) spent 9.6282 million Hong Kong dollars to repurchase 600,000 shares on March 12th.

12/03/2025

GMT Eight

Swire Properties (01972) announced that the company will spend 9.6282 million Hong Kong dollars to repurchase 600,000 shares on March 12, 2025, at a repurchase price ranging from 15.9 to 16.14 Hong Kong dollars per share.

Chengda Pharmaceuticals (301201.SZ) faces a reduction of 860,000 shares by its major shareholder, Qianhai Shengtai.

Metallurgical Corporation of China (01618): Executive Director and Vice President Bai Xiaohu is acting as the person in charge of finance.

Contact: contact@gmteight.com

SWIRE PROPERTIES (01972) spent 9.6282 million Hong Kong dollars to repurchase 600,000 shares on March 12th.

RECOMMEND

SHANSHUI CEMENT (00691) announced its performance for 2024, with a net loss attributable to owners of approximately 141 million yuan, narrowed by 84.09% year-on-year.

A femtosecond laser corneal refractive surgery system and related consumables produced by an important upstream partner represented by GAUSH MEDITECH (02407) have obtained the Medical Device Registration Certificate from the National Medical Products Administration.

LEON INSPECTION (01586): Achieving breakthroughs in innovative application technologies and officially deploying them in three major application scenarios.